Top-News
Biotechnologie USA

CV Sciences News

Aktie
WKN:  A2ALU7 ISIN:  US1266541028 US-Symbol:  CVSI
0,052 $
+0,0021 $
+4,21%
16.05.24 21:26:48
Handeln Depot/Watchlist
Aktienanzahl *
154,60 Mio.
Marktkapitalisierung *
7,09 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 27.10.2023

CV Sciences News

14.05.24 - PR Newswire
CV Sciences, Inc. Reports First Quarter 2024 Financial Results
CV Sciences, Inc. Reports First Quarter 2024 Financial Results PR Newswire
13.05.24 - PR Newswire
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER PR Newswire
08.05.24 - PR Newswire
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024 PR Newswire
28.03.24 - PR Newswire
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results PR Newswire
26.03.24 - PR Newswire
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews PR Newswire
21.03.24 - PR Newswire
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024 PR Newswire
12.12.23 - PR Newswire
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-​Based Food Market, Opening Door For European Distribution PR Newswire
14.11.23 - PR Newswire
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results PR Newswire
09.11.23 - PR Newswire
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023 PR Newswire
05.09.23 - PR Newswire
CV Sciences, Inc. Launches Reserve Sleep Gummies
CV Sciences, Inc. Launches Reserve Sleep Gummies PR Newswire
14.08.23 - PR Newswire
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results PR Newswire
01.08.23 - PR Newswire
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023
CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023 PR Newswire
01.06.23 - PR Newswire
CV Sciences to Participate in LD Micro Invitational Conference
CV Sciences to Participate in LD Micro Invitational Conference PR Newswire
15.05.23 - PR Newswire
CV Sciences, Inc. Reports First Quarter 2023 Financial Results
CV Sciences, Inc. Reports First Quarter 2023 Financial Results PR Newswire
09.05.23 - PR Newswire
CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023
CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023 PR Newswire
03.04.23 - PR Newswire
CV Sciences, Inc. Introduces New THC Offering
CV Sciences, Inc. Introduces New THC Offering PR Newswire
29.03.23 - PR Newswire
CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results
CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results PR Newswire
24.03.23 - PR Newswire
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023 PR Newswire
23.03.23 - PR Newswire
CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction
CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco ...
21.03.23 - PR Newswire
CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels
CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels PR Newswire

Newssuche

Videos

newspaper
14.05.24 -16,04%
Technical Trading: DAX dienstags Long
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »